TCS-OX2-29

CAS No. 372523-75-6

TCS-OX2-29( —— )

Catalog No. M19326 CAS No. 372523-75-6

TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 58 In Stock
10MG 87 In Stock
25MG 170 In Stock
50MG 250 In Stock
100MG 447 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TCS-OX2-29
  • Note
    Research use only, not for human use.
  • Brief Description
    TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.
  • Description
    TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.
  • In Vitro
    TCS-OX2-29 inhibits orexin A induced IP3 accumulation and ERK1/2 phosphorylation in CHO cells transfected with the OX2 receptor.
  • In Vivo
    TCS-OX2-29 (5-10 mg/kg; intraperitoneal injection; adult male NMRI mice) treatment suppresses conditioned place preference (CPP) acquisition and expression in both na?ve and dependent mice significantly. Animal Model:440 adult male NMRI mice (25-30 g)Dosage:5 mg/kg and 10 mg/kg Administration:Intraperitoneal injection (Pharmacokinetic study) Result:Suppressed conditioned place preference (CPP) acquisition and expression in both na?ve and dependent mice significantly.
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Kinesin
  • Recptor
    OX2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    372523-75-6
  • Formula Weight
    397.51
  • Molecular Formula
    C23H31N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : < 0.1 mg/mL
  • SMILES
    COC1=C(OC)C=C2CN(CCC2=C1)C(=O)[C@@H](NCC1=CC=NC=C1)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hirose M et al. N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidicantagonist. Bioorg Med Chem Lett, 2003 Dec 15, 13(24):4497-9.
molnova catalog
related products
  • KSP-IA

    A potent, specific, allosteric and cell-active inhibitor of KSP with IC50 of 11 nM; has no ihibitory activity toward other kinesins.

  • Kif15-IN-2

    Kif15-IN-2 is a kinesin Kif15 inhibitor with potential anticancer activity and can be used in prostate cancer research.

  • S-Trityl-L-cysteine

    S-Trityl-L-cysteine (NSC 83265) is a potent, cell-permeable, selective inhibitor of mitotic kinesin Eg5, inhibits basal ATPase activity (IC50=1 mM) and microtubule-activated ATPase activity of Eg5 (IC50=140 nM).